Gene Expression Analysis of Peripheral Blood Cells Reveals Toll-Like Receptor Pathway Deregulation in Colorectal Cancer

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Xu, Ye ^a,b   Xu, Qinghua ^a,b,c   Yang, Li ^a,b   Liu, Fang ^b,c   Ye, Xun ^b,c   Wu, Fei ^b,c   Ni, Shujuan ^a,b   Tan, Cong ^a,b   Cai, Guoxiang ^a,b   Meng, Xia ^b,c   Cai, Sanjun ^a,b   Du, Xiang ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR; TRANSCRIPTOME;

ADULT; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE TECHNOLOGY; HUMAN; HUMAN CELL; IMMUNITY; IRAK3 GENE; MALE; MD2 GENE; MICROARRAY ANALYSIS; MOLECULAR GENETICS; SIGNAL TRANSDUCTION; TLR1 GENE; TLR2 GENE; TLR4 GENE; TLR8 GENE; UPREGULATION; AGED; CASE CONTROL STUDY; COLORECTAL TUMOR; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTOME;

EID: 84877026510     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062870     Document Type: Article

References (47)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Walsh JM, Terdiman JP, (2003) Colorectal cancer screening: scientific review. JAMA 289: 1288-1296.
3. Han M, Liew CT, Zhang HW, Chao S, Zheng R, et al. (2008) Novel blood-based, five-gene biomarker set for the detection of colorectal cancer. Clin Cancer Res 14: 455-460.
4. Aaroe J, Lindahl T, Dumeaux V, Saebo S, Tobin D, et al. (2010) Gene expression profiling of peripheral blood cells for early detection of breast cancer. Breast Cancer Res 12: R7.
5. Marshall KW, Mohr S, Khettabi FE, Nossova N, Chao S, et al. (2010) A blood-based biomarker panel for stratifying current risk for colorectal cancer. Int J Cancer 126: 1177-1186.
6. Zander T, Hofmann A, Staratschek-Jox A, Classen S, Debey-Pascher S, et al. (2011) Blood-based gene expression signatures in non-small cell lung cancer. Clin Cancer Res 17: 3360-3367.
7. Rotunno M, Hu N, Su H, Wang C, Goldstein AM, et al. (2011) A gene expression signature from peripheral whole blood for stage I lung adenocarcinoma. Cancer Prev Res (Phila) 4: 1599-1608.
8. Yang B, Xu Q, Wu F, Liu F, Ye X, et al. (2011) Using peripheral blood mRNA signature to distinguish between breast cancer and benign breast disease in non-conclusive mammography patients. Cancer Biol Ther 10: 1235-1239.
9. Xu Y, Xu Q, Ni S, Liu F, Cai G, et al. (2011) Decrease in natural killer cell associated gene expression as a major characteristic of the immune status in the bloodstream of colorectal cancer patients. Cancer Biol Ther 11: 188-195.
10. Terzic J, Grivennikov S, Karin E, Karin M, (2010) Inflammation and colon cancer. Gastroenterology 138: 2101-2114.
11. Burczynski ME, Dorner AJ, (2006) Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies. Pharmacogenomics 7: 187-202.
12. Mohr S, Liew CC, (2007) The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med 13: 422-432.
13. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, et al. (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7: 3.
14. Parkinson H, Sarkans U, Kolesnikov N, Abeygunawardena N, Burdett T, et al. (2011) ArrayExpress update-an archive of microarray and high-throughput sequencing-based functional genomics experiments. Nucleic Acids Res 39: D1002-D1004.
15. Ihaka R, Gentleman R, (1996) R: A Language for Data Analysis and Graphics. Journal of Computational and Graphical Statistics 5: 299-314.
16. Reimers M, Carey VJ, (2006) Bioconductor: an open source framework for bioinformatics and computational biology. Methods Enzymol 411: 119-134.
17. Wilson CL, Miller CJ, (2005) Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics 21: 3683-3685.
18. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
19. Gautier L, Cope L, Bolstad BM, Irizarry RA, (2004) affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315.
20. Maglott D, Ostell J, Pruitt KD, Tatusova T, (2011) Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 39: D52-D57.
21. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
22. Storey JD, Tibshirani R, (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100: 9440-9445.
23. Tsai CA, Hsueh HM, Chen JJ, (2003) Estimation of false discovery rates in multiple testing: application to gene microarray data. Biometrics 59: 1071-1081.
24. Blake JA, Harris MA, (2008) The Gene Ontology (GO) project: structured vocabularies for molecular biology and their application to genome and expression analysis. Curr Protoc Bioinformatics Chapter 7: 2-7.
25. Mi H, Thomas P, (2009) PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Methods Mol Biol 563: 123-140.
26. Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A, (2012) GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res 40: W478-W483.
27. Stamova BS, Apperson M, Walker WL, Tian Y, Xu H, et al. (2009) Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood. BMC Med Genomics 2: 49.
28. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: H34.
29. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, et al. (2008) A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29: 150-164.
30. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, et al. (2002) Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277: 15028-15034.
31. Tang D, Kang R, Zeh HR, Lotze MT, (2010) High-mobility group box 1 and cancer. Biochim Biophys Acta 1799: 131-140.
32. Kawai T, Akira S, (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650.
33. Qin LX, Beyer RP, Hudson FN, Linford NJ, Morris DE, et al. (2006) Evaluation of methods for oligonucleotide array data via quantitative real-time PCR. BMC Bioinformatics 7: 23.
34. Hanash SM, Baik CS, Kallioniemi O, (2011) Emerging molecular biomarkers-blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol 8: 142-150.
35. Medzhitov R, Preston-Hurlburt P, Janeway CJ, (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
36. Beutler B, (2004) Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263.
37. Medzhitov R, (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135-145.
38. Iwasaki A, Medzhitov R, (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987-995.
39. Sato Y, Goto Y, Narita N, Hoon DS, (2009) Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment. Cancer Microenviron 2Suppl 1: 205-214.
40. Chen R, Alvero AB, Silasi DA, Steffensen KD, Mor G, (2008) Cancers take their Toll-the function and regulation of Toll-like receptors in cancer cells. Oncogene 27: 225-233.
41. Basith S, Manavalan B, Yoo TH, Kim SG, Choi S, (2012) Roles of toll-like receptors in cancer: a double-edged sword for defense and offense. Arch Pharm Res 35: 1297-1316.
42. Swann JB, Vesely MD, Silva A, Sharkey J, Akira S, et al. (2008) Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc Natl Acad Sci U S A 105: 652-656.
43. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, et al. (2007) Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133: 1869-1881.
44. Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, et al. (2010) High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer 102: 908-915.
45. Cammarota R, Bertolini V, Pennesi G, Bucci EO, Gottardi O, et al. (2010) The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker. J Transl Med 8: 112.
46. Zarember KA, Godowski PJ, (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168: 554-561.
47. Jass JR, (2007) Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50: 113-130.